Sambucus Immune Lozenges
On sale on the US market (according to the DSLD)
Nature's Way, food supplement from the US market
Sambucus Immune Lozenges (Nature's Way), a food supplement au code-barres 033674140017, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 400 mg a day according to the label (at most 4 servings a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Nature's Way
- Barcode
- 033674140017
- Form
- Lozenge
- One serving
- 1 lozenge
- Servings
- up to 4 servings per day
- Other ingredients (in English, as written)
- Sucrose, Fructose, Magnesium Stearate, Silica, Natural Flavors
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Total Carbohydrates | Carbohydrate | not stated |
| Total Sugars | Carbohydrate | not stated |
| Added Sugars | Carbohydrate | not stated |
| Vitamin C | Vitamin | 100 mg |
| Black Elderberry Extract (Sambucus nigra) | Plant | 100 mg |
| Elderberry (Sambucus nigra) | Plant | 6,400 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Sambucus Original Lozenges
Entered into DSLD on 21 July 2022. Withdrawn from the US market on 20 December 2024 (according to the DSLD).Same active composition.
Official label: Sambucus Original Lozenges
Entered into DSLD on 22 January 2021. Withdrawn from the US market on 30 September 2021 (according to the DSLD).- Active ingredient added : premium cultivar Elderberries (6.4 Gram(s))
- Active ingredient removed : Elderberry (6,400 mg)
- Same quantity, different name: Black Elder (Sambucus nigra L.) extract in this version; Black Elderberry Extract on the displayed label (100 mg)
Official label: Sambucus Original Lozenges
Entered into DSLD on 24 July 2019. Withdrawn from the US market on 16 December 2020 (according to the DSLD).- Active ingredient added : premium cultivar Elderberries (6.4 Gram(s))
- Active ingredient removed : Elderberry (6,400 mg)
- Same quantity, different name: Black Elder (Sambucus nigra L.) extract in this version; Black Elderberry Extract on the displayed label (100 mg)
Official label: Sambucus Original Lozenges
Entered into DSLD on 25 April 2019. Withdrawn from the US market on 3 December 2018 (according to the DSLD).- Active ingredient added : premium cultivar Elderberries (6.4 Gram(s))
- Active ingredient removed : Elderberry (6,400 mg)
- Same quantity, different name: Black Elder (Sambucus nigra L.) extract in this version; Black Elderberry Extract on the displayed label (100 mg)
Official label: Original Sambucus
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 21 June 2018 (according to the DSLD).- Active ingredient added : premium cultivar Elderberries (6.4 Gram(s))
- Active ingredient added : Sugar (< 1 Gram(s))
- Active ingredient removed : Added Sugars (< 1 Gram(s))
- Active ingredient removed : Elderberry (6,400 mg)
- Active ingredient removed : Total Sugars (< 1 Gram(s))
Official label: Original Sambucus
Entered into DSLD on 23 December 2016. Withdrawn from the US market on 13 April 2017 (according to the DSLD).- Active ingredient added : Sugar (< 1 Gram(s))
- Active ingredient removed : Added Sugars (< 1 Gram(s))
- Active ingredient removed : Elderberry (6,400 mg)
- Active ingredient removed : Total Sugars (< 1 Gram(s))
- Same quantity, different name: Black Elderberry (berry) extract in this version; Black Elderberry Extract on the displayed label (100 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Black Elderberry Extract
Read the warning, when it applies and the studies cited
ELDER – SAMBUCUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).
Sources cited by Health Canada (1)
- Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Nature's Way
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Sambucus Immune Lozenges (Nature's Way): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/33674140017-sambucus-immune-lozenges-nature-s-way, updated 21 May 2025.